GeneDx Holdings Corp. updated revenue guidance for the full year 2023. Drive full year 2023 revenues of $187 million to $192 million (updated from previous guidance of $205 million to $220 million).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.38 USD | +12.67% | +19.77% | +750.18% |
04-30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
04-30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+750.18% | 611M | |
-13.90% | 8.58B | |
+60.25% | 4.12B | |
-43.01% | 2.29B | |
-10.16% | 2.44B | |
-2.85% | 2.48B | |
-3.40% | 2B | |
-19.79% | 1.53B | |
-40.57% | 1.21B | |
+9.11% | 1.12B |
- Stock Market
- Equities
- WGS Stock
- News GeneDx Holdings Corp.
- GeneDx Holdings Corp. Updates Revenue Guidance for the Full Year 2023